Search results
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 5 hours agoThe Sanofi agreement even prompted Novavax to say it now no longer is at risk of shutting its doors. But does this mean Novavax could become a leader in...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 3 hours agoThe review is now expected to be completed by the end of this month. The FDA, however, did not...
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 21 hours agoThere's a new approach that people are trying, which is called an RNA vaccine, which is what this ...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 2 days agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy? | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA -4.38%) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Is This a Setback for Moderna?
The Motley Fool via AOL· 3 days agoSo, this isn't a setback for Moderna, and investors can breathe a sigh of relief. But it's still important to keep a close eye on the situation for one...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 7 hours agoNBC Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent 13F filing ...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 7 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...